Crinetics Pharmaceuticals earnings were -$298.4M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. The latest CRNX earnings report on Dec 31, 2024 announced Q4 2024 earnings of -$80.6M, up 4.9% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, CRNX reported annual earnings of -$298.4M, with 39.1% growth. The next CRNX earnings date is May 7, 2025.
Crinetics Pharmaceuticals Earnings Reports & History FAQ
What were Crinetics Pharmaceuticals's earnings last quarter?
On CRNX's earnings call on Invalid Date, Crinetics Pharmaceuticals (NASDAQ: CRNX) reported Q4 2024 earnings per share (EPS) of -$0.87, up 1.14% year over year. Total CRNX earnings for the quarter were -$80.60 million. In the same quarter last year, Crinetics Pharmaceuticals's earnings per share (EPS) was -$0.88.
When does Crinetics Pharmaceuticals report earnings?
The next CRNX earnings date is Invalid Date. Add CRNX to your watchlist to be reminded of Crinetics Pharmaceuticals's next earnings date.
What was CRNX's earnings growth in the past year?
As of Crinetics Pharmaceuticals's earnings date in Invalid Date, Crinetics Pharmaceuticals's earnings has grown year over year. CRNX earnings in the past year totalled -$298.41 million.
Is Crinetics Pharmaceuticals profitable or losing money?
As of the last Crinetics Pharmaceuticals earnings report, Crinetics Pharmaceuticals is currently losing money. Crinetics Pharmaceuticals's net profit (also called net income) for the twelve months ending Dec 31, 2024 was -$298.41 million, a 39.1% increase year over year.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.